Posts tagged ‘Marketing Strategy Consultant’
August 2nd, 2011
It takes desire, discipline and determination to blog regularly, and as a result many blogs fall by the wayside over time. However, Sally Church has been writing a blog on oncology, hematology, cancer science & biology, clinical trials and new product development for the past five years. It continues to go from strength to strength thanks to Sally’s passion for the area.
Sally recently announced on Pharma Strategy Blog that she had reached the 900 blog post milestone. In recognition of this, Sally took the time to answer the follow questions:
- Why do you blog?
- How do you decide what to write about?
- What makes a good blog post?
- Looking back on 900 posts – which posts are most memorable?
- What are your future goals for Pharma Strategy Blog?
You can find out Sally’s answers in the following video:
February 11th, 2011
Following on from news about the emerging competitive landscape in osteoporosis, Pieter Droppert on the Biotech Strategy Blog considers in more detail Merck’s odanacatib, currently in phase III clinical trials.
Odanacatib is first of a new class of drugs for the treatment of osteoporosis known as cathepsin K inhibitors (CAT-K). You can read more on Biotech Strategy Blog about this new product, its mechanism of action and the marketing strategy associated with its development.